ALINT

IntegraGen SA

FR Healthcare Biotechnology

Latest week
10 Jul 2026
Close
0.152500
Fair value
0.546591
Next-week expectancy
Negative 36.56%
Sharemaestro

ALINT Chart Pack

IntegraGen SA

Exchange
PAR
Latest week
10 Jul 2026
Close
0.152500
Fair value
0.546591
Next-week expectancy
Negative 36.56%
Generated
16 Jul 2026 22:28
Sector
Healthcare
Industry
Biotechnology

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, ALINT fell 5.86%, moving from 0.16 to 0.15. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is -20.30 and has improved across the 12-week window. Market Dynamics is -0.09 on the latest week. Next-week expectancy is negative at 36.56% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
0.15
12-Week Change
-5.86%
Trend Signal
Active
Next-Week Expectancy
Negative 36.56%
Signal Weeks
12 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-20.30
Market Dynamics
-0.09

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
0.15
12-Week Change
-5.86%
Trend Signal
Active
Next-Week Expectancy
Negative 36.56%
Signal Weeks
12 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-20.30
Market Dynamics
-0.09

Over the latest 12 completed weeks ending 2026-07-10, ALINT fell 5.86%, moving from 0.16 to 0.15. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is -20.30 and has improved across the 12-week window. Market Dynamics is -0.09 on the latest week. Next-week expectancy is negative at 36.56% based on similar historical setup states.

Industry Peers

France equities in Biotechnology

Stock Exchange Week Open High Low Close Change
ALPAT Plant Advanced Technologies SA PAR 10 Jul 2026 5.50 6.40 5.50 6.40 16.36%
ALDVI Advicenne S.A. PAR 10 Jul 2026 1.54 2.21 1.48 1.77 14.94%
IVA Inventiva S.A. PAR 10 Jul 2026 3.41 4.05 3.27 3.73 9.54%
GNFT Genfit S.A. PAR 10 Jul 2026 13.20 14.32 12.32 13.74 4.09%
ALTHX THX Pharma Société Anonyme PAR 10 Jul 2026 3.66 3.89 3.37 3.74 2.19%
NANO Nanobiotix S.A. PAR 10 Jul 2026 34.90 37.16 32.10 35.56 1.89%
AELIS Aelis Farma SA PAR 10 Jul 2026 1.04 1.10 1.00 1.05 0.96%
ALOPM Oncodesign Precision Medicine Société anonyme PAR 10 Jul 2026 0.34 0.35 0.31 0.34 0.29%
POXEL Poxel S.A. PAR 10 Jul 2026 0.20 0.21 0.19 0.20 0.25%
ALBPS Biophytis S.A. PAR 10 Jul 2026 0.02 0.02 0.02 0.02 0.00%
ALGAE FERMENTALG PAR 10 Jul 2026 0.50 0.52 0.49 0.50 0.00%
ALGEN genOway Société anonyme PAR 10 Jul 2026 2.40 2.45 2.21 2.40 0.00%
ALSEN Sensorion SA PAR 10 Jul 2026 0.26 0.28 0.25 0.26 0.00%
MLINA INMOLECULE NANOTECH, S.A. PAR 10 Jul 2026 4.08 4.08 4.08 4.08 0.00%
TNG Transgene SA PAR 10 Jul 2026 0.76 0.78 0.74 0.76 0.00%
SIGHT GenSight Biologics S.A. PAR 10 Jul 2026 0.08 0.09 0.08 0.08 -1.08%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.